Restructure Information

On September 15, 2019, Purdue announced a preliminary agreement to settle the massive opioid litigation facing the Company. To implement this settlement and secure a final resolution of all pending litigation, Purdue and its subsidiaries voluntarily filed petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code.

If you believe you have a claim against Purdue or any of its subsidiaries, please click “Read More Here” below for further information about the Proof of Claim process. JULY 30, 2020 is the “Bar Date” – THE DEADLINE for every person or entity to submit a Proof of Claim.

Speaking Out Against Systemic Racism

WE FEEL compelled at this moment to speak out about the unacceptable and disturbing acts of racial injustice that have brought our nation to an inflection point.

WE BELIEVE that any form of racism or racial suppression is wrong. We believe that addressing injustice must be a priority for us all.  We believe that people have the right to protest peacefully. We believe that compassion and understanding happen only when we truly open our hearts and listen.

WE WILL do our part. We will continue to provide a safe and welcoming environment for our employees. We will foster an environment that encourages open dialogue, opportunities, and support for individuals from all backgrounds. We will not tolerate racial discrimination or harassment in our ranks. We will continue to support organizations that provide services for underserved populations in communities where we live, work and serve. And we will listen so we can do better in honoring these commitments.

Read about our commitment to safety as we navigate coronavirus here

RECENT NEWS

Purdue Taps Tom Vilsack, former Cabinet Secretary and Governor, to Monitor Compliance With Voluntary Injunction

Purdue Pharma L.P. (“Purdue”) today announced the appointment of former United States Agriculture Secretary and Iowa Governor Tom Vilsack as Monitor under the voluntary self-injunction approved on…

Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlement

Purdue’s entire value to be contributed for the benefit of the American public Settlement is estimated to provide more than $10 billion of value to address opioid crisis, including potentially…

The Prescription Drug Safety Network Significantly Expands Its Reach in Year 2 and Reports an Average 48% Knowledge Gain Nationwide

Purdue announces expanded support for the Prescription Drug Safety course through an additional sponsorship in Tennessee STAMFORD, Conn. – August 20, 2019 — Purdue Pharma L.P. (“Purdue”), a founding…

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parities’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.